Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 1,991 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 1 Clear all

Conditions: Distress, Depression, Grief
Interventions: Psilocybin, Modified brief Supportive Expressive Group Therapy; Drug · Behavioral
Lead sponsor: Joshua Woolley; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Infections, Meningococcal
Interventions: 4CMenB; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Copd
Interventions: Self-management education (short), Ground-based walking training, Inhaler training, Caregiver support, Self-management education (long); Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 40 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID-19, Diagnostic Test
Interventions: Lollipop; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 4 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Well-Being, Psychological
Interventions: mental health app; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Erie, Pennsylvania

Conditions: Active Breast Cancer Treatment
Interventions: Checklist, MyChart, OpenNotes, Usual Care; Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Baltimore, Maryland • Lutherville, Maryland

Conditions: Sugary Beverages
Interventions: weSIPsmarter, weLearn2Read; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 2 Years and older
Enrollment: 744 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Christiansburg, Virginia

Conditions: Diabetes Mellitus, Diabetic Retinopathy
Interventions: EyePromise DVS, EyePromise DVS plus EyePromise EZTears; Dietary Supplement
Lead sponsor: ZeaVision, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Diabetes Mellitus, Hypertension
Interventions: NOTES, AUDIO; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,022 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Manchester, New Hampshire • Nashville, Tennessee • Galveston, Texas

Conditions: Multiple Myeloma
Interventions: Pomalidomide, Dexamethasone, Daratumumab; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 33
States / cities: Tucson, Arizona • Greenbrae, California • Los Angeles, California + 28 more

Conditions: Spina Bifida
Interventions: PedMMSWC Wheelchair User Testing, PedMMSWC Simulated Home, School, Community Environment; Device
Lead sponsor: Optimal Mobility, Inc; Industry
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Diabetes Mellitus, Type 1
Interventions: CGM and Insulin Pump, Closed-Loop Control System; Device
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 21 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 3
States / cities: Santa Barbara, California • Rochester, Minnesota • Charlottesville, Virginia

Conditions: Prescribing Patterns, Physician, Physician's Practice Patterns, Drug Utilization Review
Interventions: Algorithmic Defaulting (Indication-Based Default), Active Physician Choice; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 50 Years and older
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV Prevention, HCV, Opioid Use, Intravenous Drug Usage
Interventions: ARTAS Adapted Patient Navigation, Adherence Counseling; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 446 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Miami, Florida • New York, New York

Conditions: Bulimia
Interventions: Cognitive Behavioral Therapy for Adolescents, Supportive Psychotherapy, Family Based Therapy for Bulimia Nervosa; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Stanford, California • Chicago, Illinois

Conditions: Pediatric Obesity, Nutrition Disorder
Interventions: Nourish to Flourish: The Power of Positive Food Parenting; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 5 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Albuterol eMDPI DS; Combination Product
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 40 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Healthy Volunteer
Interventions: Information absent, Information; Other
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 18 Years and older
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Spinal Cord Injuries
Interventions: Epidural stimulation + Stand Training, Epidural stimulation + Step Training, Epidural stimulation + Bladder Capacity Training, Epidural stimulation + Bladder Voiding Efficiency Training; Combination Product
Lead sponsor: Claudia Angeli; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Newly Diagnosed Glioblastoma
Interventions: Nivolumab, Relatlimab, TMZ, Radiation Therapy; Drug · Radiation
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 3
States / cities: New York, New York • Durham, North Carolina • Houston, Texas

Conditions: PreDiabetes, Prediabetic State, Overweight and Obesity
Interventions: PreventT2 (Individual intervention), PreventT2 Together (Couple-based intervention); Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Fanconi Anemia, Head and Neck Cancer, Squamous Cell Carcinoma, Squamous Cell Cancer of Head and Neck (SCCHN)
Interventions: Metformin, Naproxen Sodium; Drug
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Minneapolis, Minnesota • New York, New York

Conditions: Urinary Incontinence
Interventions: PureWick® Urine Collection System, UltraFlex™ Self-Adhering Male External Catheter; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 65 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Greenacres City, Florida • Hamilton, New Jersey

Conditions: Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma
Interventions: Bevacizumab, Electric Field Therapy, NovoTTF-200A Device, Quality-of-Life Assessment; Biological · Procedure · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 8
States / cities: Santa Monica, California • Miami, Florida • Atlanta, Georgia + 5 more

Search by objective public record fields.

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Safety of 4CMenB Exposure During Pregnancy

Optimizing Self-management COPD Treatment Through the American Lung Association Helpline

Inpatient COVID-19 Lollipop Study

Mental Health App and Impact on Wellbeing

Involving Family to Improve Communication in Breast Cancer Care

weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents

Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support

Integrated HIV Prevention and HCV Care for PWID

Study of Treatment for Adolescents With Bulimia Nervosa

A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

Patient Provider Communication and Interaction in a Virtual Clinical Setting

Locomotor and Bladder Function in Individuals With Acute Spinal Cord Injury

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Couple-Based Lifestyle Intervention to Prevent Type 2 Diabetes

Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia

This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma